US Patent 10035760 Inhibitors of human immunodeficiency virus replication
Patent 10035760 was granted and assigned to ViiV Healthcare on July, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+213 characters)
Article
Patent abstract
Compounds of Formula I with activity against HIV, including pharmaceutical compositions and methods for using these compounds in treating human immunodeficiency virus (HIV) infection, are set forth:
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Alan Xiangdong Wang0
Annapurna Pendri0
Brett R. Beno0
Guo Li0
John A. Bender0
Makonen Belema0
Nicholas A. Meanwell0
Robert A. Fridell0
Robert G. Gentles0
Zhong Yang0
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100357600
Date of Patent
July 31, 2018
0Patent Application Number
150313520
Date Filed
October 23, 2014
0Patent Primary Examiner
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10035760 Inhibitors of human immunodeficiency virus replication
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10035760
Date of patent
July 31, 2018
Patent application number
15031352
Date Filed
October 23, 2014
Patent primary examiner
Find more entities like US Patent 10035760 Inhibitors of human immunodeficiency virus replication
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.